Abstract:Objective: The purpose of this study was to investigate the specific alterations in gut microbiome and serum metabolome and their interactions in patients with polycystic ovary syndrome (PCOS). Methods: The stool samples from 32 PCOS patients and 18 healthy controls underwent the intestinal microbiome analysis using shotgun metagenomics sequencing approach. Serum metabolome was analyzed by ultrahigh performance liquid chromatography quadrupole time-of-flight mass spectrometry. An integrative network by combining metagenomics and metabolomics datasets was constructed to explore the possible interactions between gut microbiota and circulating metabolites in PCOS, which was further assessed by fecal microbiota transplantation (FMT) in a rat trial. Results: Fecal metagenomics identified 64 microbial strains significantly differing between PCOS and healthy subjects, half of which were enriched in patients. These changed species showed an ability to perturb host metabolic homeostasis (including insulin resistance and fatty acid metabolism) and inflammatory levels (such as PI3K/Akt/mTOR signaling pathways) by expressing sterol regulatory element-binding transcription factor-1, serine/threonine-protein kinase mTOR, and 3-oxoacyl-[acyl-cattier-protein] synthase III, possibly suggesting the potential mechanisms of gut microbiota underlying PCOS. By integrating multi-omics datasets, the panel comprising seven strains ( Achromobacter xylosoxidans , Pseudomonas sp. M1, Aquitalea pelogenes , Porphyrobacter sp. HL-46, Vibrio fortis , Leisingera sp. ANG-Vp, and Sinorhizobium meliloti ) and three metabolites [ganglioside GM3 (d18:0/16:0), ceramide (d16:2/22:0), and 3Z,6Z,9Z-pentacosatriene] showed the highest predictivity of PCOS (AUC: 1.0) with sensitivity of 0.97 and specificity of 1.0. Moreover, the intestinal microbiome modifications by FMT were demonstrated to regulate PCOS phenotypes including metabolic variables and reproductive hormones. Conclusion: Our findings revealed key microbial and metabolite features and their interactions underlying PCOS by integrating multi-omics approaches, which may provide novel insights into discovering clinical diagnostic biomarkers and developing efficient therapeutic strategies for PCOS.

Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review

Unveiling the complex interplay between gut microbiota and polycystic ovary syndrome: A narrative review

Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota

Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: A review

Roles of Gut Microbiota in the Occurrence and Development of Polycystic Ovary Syndrome

Gut Microbiota As a Potential Target for Treatment of Polycystic Ovary Syndrome

Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications

Association between Polycystic Ovary Syndrome and Gut Microbiota

Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review

Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome

Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects

Metagenomic Analysis Identified Microbiome Alterations and Pathological Association Between Intestinal Microbiota and Polycystic Ovary Syndrome

Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic Strategy

Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies

Interaction of PCOS with the Reproductive Tract and Gut Microbiome

A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota

Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome

Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus

A review of metabolic and microbial influences on women with polycystic ovarian syndrome

Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health